DEMO=0 python3 build.py after wiring real content.Semaglutide, tirzepatide or retatrutide — blind. You do not tell us which you suspect.
The most-ordered peptide test there is. Send one unopened vial and we identify which of the three GLP-1 peptides is inside, measure how much is in the vial, and report peptide purity. If the vial contains a mixture, every component is identified and measured separately. Blind means blind: you do not have to declare what you think is in there, which is what makes the result worth anything to a third party.
Confirms the molecule is what the label claims, by measuring the mass of the eluting ions. Catches substitution and the wrong compound entirely.
How much is actually in the vial, compared against the declared strength and reported as a percentage of claim.
Area percent of the main peak, with the chromatogram attached so the figure can be checked rather than trusted.
A report ID and unique key that resolve to a public record. Anything that does not resolve is not a genuine report.
| Target compounds | Semaglutide, Tirzepatide, Retatrutide |
|---|---|
| Other names | Sema, Tirz, Reta, RT30, TR30 |
| CAS — Semaglutide | 910463-68-2 |
| Molecular weight — Semaglutide | 4113.6 |
| CAS — Tirzepatide | 2023788-19-2 |
| Molecular weight — Tirzepatide | 4813.5 |
| CAS — Retatrutide | 2381089-83-2 |
| Molecular weight — Retatrutide | 4731.3 |
| Testing method | RP-HPLC-UV 214 nm + ESI-LC-MS |
| Detection limit | below 1/20th of a usual dose per vial |
| Result format | mg per vial, purity %, identity confirmed |
| Minimum sample | 1 whole unopened vial, or 30 mg raw API in a sealed glass vial |
No. That is the point of a blind test. We identify it from the sample.
Then all three are identified and measured. Purity may be reported per component rather than as a single figure.
Yes. Vial size does not change the price; the assay scales.
Add any of these to the same vial, on the same certificate.
Describe the sample and we will tell you what to order — or whether we can test it at all.